A critical goal of drug development is getting the dose right. Under-dosing can result in a lack of efficacy, and overdosing can result in adverse effects. Most drugs given to neonates have not been ...
Gemcitabine and vinorelbine as third-line therapy in elderly patients (pts) with advanced breast cancer (ABC) pretreated with taxanes and anthracyclines Has been demonstrated that 10–20 μg/mL is the ...
High-dose erythropoietin (Epo) is a promising neuroprotective treatment in neonates with hypoxic–ischemic encephalopathy (HIE) receiving hypothermia. We evaluated the pharmacokinetics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback